Montreal - Millenia Hope Inc. has acquired the global patent rights to develop, manufacture and distribute, for all indications, Tetrandrine from inventor Dr. Knox Van Dyke, an internationally renowned researcher from the University of West Virginia.
Millenia Hope is focused on the development of anti-malaria products and is actively engaged in the fight against this disease that claims nearly three million lives every year. Tetrandrine aids the treatment of drug-resistant strains of malaria when administered together with standard therapies.
"Tetrandrine adds to our pipeline of products targeting malaria, which include MMH18/ MMHMalarex and Malarex, currently in further …
No comments:
Post a Comment